Oncology pharmacist · National Cancer Center Tokyo · Japan (JP) · Oncology
Data minimisation
Cadence target for Tier 1: 4 per year (assumption)
1 of 2 expected engagements
All engagements including drafts, newest first
| Date | Type | Format | MSL | Product | Topics | Insights | Flags | Status | |
|---|---|---|---|---|---|---|---|---|---|
| 22 Mar 2026 | Payer / HTA meeting | In person | Mei Tanaka | Vantrexa | Chemotherapy-free first line | 1 | — | Reviewed | ENG-0069 |
22 Mar 2026
Chemotherapy-free first line
National Cancer Center Tokyo
Radiation oncologist
Oncology pharmacist
Primary care physician
Headache specialist